CIRAK, Sebahattin, Aileen Reghan FOLEY, Ralf HERRMANN, Tobias WILLER, Shu YAU, Elizabeth STEVENS, Silvia TORELLI, Lina BRODD, Alisa KAMYNINA, Petr VONDRÁČEK, Helen ROPER, Cheryl LONGMAN, Rudolf KORINTHENBERG, Gianni MARROSU, Peter NUERNBERG, Daniel E MICHELE, Vincent PLAGNOL, Matt HURLES, Steven A MOORE, Caroline A SEWRY, Kevin P CAMPBELL, Thomas VOIT and Francesco MUNTONI. ISPD gene mutations are a common cause of congenital and limb-girdle muscular dystrophies. Brain. OXFORD: OXFORD UNIV PRESS, 2013, vol. 136, Part 1, p. 269-281. ISSN 0006-8950. Available from: https://dx.doi.org/10.1093/brain/aws312.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name ISPD gene mutations are a common cause of congenital and limb-girdle muscular dystrophies
Authors CIRAK, Sebahattin (826 United Kingdom of Great Britain and Northern Ireland), Aileen Reghan FOLEY (826 United Kingdom of Great Britain and Northern Ireland), Ralf HERRMANN (276 Germany), Tobias WILLER (840 United States of America), Shu YAU (826 United Kingdom of Great Britain and Northern Ireland), Elizabeth STEVENS (826 United Kingdom of Great Britain and Northern Ireland), Silvia TORELLI (826 United Kingdom of Great Britain and Northern Ireland), Lina BRODD (826 United Kingdom of Great Britain and Northern Ireland), Alisa KAMYNINA (826 United Kingdom of Great Britain and Northern Ireland), Petr VONDRÁČEK (203 Czech Republic, guarantor, belonging to the institution), Helen ROPER (826 United Kingdom of Great Britain and Northern Ireland), Cheryl LONGMAN (826 United Kingdom of Great Britain and Northern Ireland), Rudolf KORINTHENBERG (276 Germany), Gianni MARROSU (380 Italy), Peter NUERNBERG (276 Germany), Daniel E MICHELE (840 United States of America), Vincent PLAGNOL (826 United Kingdom of Great Britain and Northern Ireland), Matt HURLES (826 United Kingdom of Great Britain and Northern Ireland), Steven A MOORE (840 United States of America), Caroline A SEWRY (826 United Kingdom of Great Britain and Northern Ireland), Kevin P CAMPBELL (840 United States of America), Thomas VOIT (250 France) and Francesco MUNTONI (826 United Kingdom of Great Britain and Northern Ireland).
Edition Brain, OXFORD, OXFORD UNIV PRESS, 2013, 0006-8950.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30000 3. Medical and Health Sciences
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 10.226
RIV identification code RIV/00216224:14110/13:00072148
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1093/brain/aws312
UT WoS 000314909900021
Keywords in English congenital muscular dystrophy; limb-girdle muscular dystrophy; dystroglycan; laminin; isoprenoid synthase
Tags International impact, Reviewed
Changed by Changed by: Ing. Mgr. Věra Pospíšilíková, učo 9005. Changed: 6/3/2014 08:48.
Abstract
Dystroglycanopathies are a clinically and genetically diverse group of recessively inherited conditions ranging from the most severe of the congenital muscular dystrophies, Walker-Warburg syndrome, to mild forms of adult-onset limb-girdle muscular dystrophy. Their hallmark is a reduction in the functional glycosylation of alpha-dystroglycan, which can be detected in muscle biopsies. An important part of this glycosylation is a unique O-mannosylation, essential for the interaction of alpha-dystroglycan with extracellular matrix proteins such as laminin-alpha 2. Mutations in eight genes coding for proteins in the glycosylation pathway are responsible for similar to 50% of dystroglycanopathy cases. Despite multiple efforts using traditional positional cloning, the causative genes for unsolved dystroglycanopathy cases have escaped discovery for several years. In a recent collaborative study, we discovered that loss-of-function recessive mutations in a novel gene, called isoprenoid synthase domain containing (ISPD), are a relatively common cause of Walker-Warburg syndrome. In this article, we report the involvement of the ISPD gene in milder dystroglycanopathy phenotypes ranging from congenital muscular dystrophy to limb-girdle muscular dystrophy and identified allelic ISPD variants in nine cases belonging to seven families. In two ambulant cases, there was evidence of structural brain involvement, whereas in seven, the clinical manifestation was restricted to a dystrophic skeletal muscle phenotype. Although the function of ISPD in mammals is not yet known, mutations in this gene clearly lead to a reduction in the functional glycosylation of alpha-dystroglycan, which not only causes the severe Walker-Warburg syndrome but is also a common cause of the milder forms of dystroglycanopathy.
PrintDisplayed: 1/5/2024 03:55